Cargando…
Clinically Applicable Assessment of Tisagenlecleucel CAR T Cell Treatment by Digital Droplet PCR for Copy Number Variant Assessment
Chimeric antigen receptor (CAR) T cell therapy is an innovative immunotherapy for treating cancers in both children and adults with proven utility in numerous clinical trials. Significantly, some CAR T cell therapies have now been approved by relevant national regulatory bodies across numerous count...
Autores principales: | Gkazi, Soragia Athina, Gravett, Emma, Bautista, Carla, Bartram, Jack, Ghorashian, Sara, Adams, Stuart Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322953/ https://www.ncbi.nlm.nih.gov/pubmed/35886920 http://dx.doi.org/10.3390/ijms23147573 |
Ejemplares similares
-
Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR
por: Schubert, Maria-Luisa, et al.
Publicado: (2020) -
Base-edited CAR T cells for combinational therapy against T cell malignancies
por: Georgiadis, Christos, et al.
Publicado: (2021) -
Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products
por: Lu, Alex, et al.
Publicado: (2020) -
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients
por: Haderbache, Rafik, et al.
Publicado: (2021) -
Detection and quantification of integrated vector copy number by multiplex droplet digital PCR in dual-transduced CAR T cells
por: Wang, Wei, et al.
Publicado: (2023)